Evusheld authorized by Health Canada

On April 14, Evusheld – the only pre-exposure long-acting monoclonal antibody for COVID-19 prevention – was authorized by Health Canada and recently supported with broad recommendations for use in immune-compromised Canadians by the Canadian Agency...

Creating a clearer picture of lupus

UM clinician scientist Dr. Lily Lim is using artificial intelligence (AI) to better recognize lupus in patients. Known as “the disease with a thousand faces” symptoms vary from person to person. Lab tests aren’t always conclusive. The autoimmune disorder is infamously...